Patients with Duffy null status are more likely to experience misdiagnoses, unnecessary medical tests, and increased health disparities.

BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented ...

The seven chimeric antigen receptor T-cell therapies approved in the United States have revolutionized treatment of blood cancers.Eight years after the first CAR-T product entered the market, members ...

Routine blood samples, such as those taken daily at any hospital and tracked over time, could help predict the severity of an injury and even provide insights into mortality after spinal cord damage, ...

A research team from the Anhui Institute of Optics and Fine Mechanics (AIOFM), the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (CAS), in collaboration with the Hefei Cancer ...

Kashiv BioSciences, LLC today announced the commercial launch of PEXEGRA®, a biosimilar referencing Neulasta®, and FILRA®, a biosimilar referencing Neupogen®, in the Canadian market. Both biosimilars ...

Every September, Blood Cancer Awareness Month emphasizes early detection and support for those affected by leukemia, lymphoma, and myeloma. Dr. Nitin Agarwal highlights key symptoms like persistent ...

Antibiotic therapy with ceftriaxone and doxycycline had no clinical or laboratory effect. The rash was assessed by dermatologists three times and was considered to be either of viral (measles PCR ...